🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ATTR Cardiac Amyloidosis in a Selected Population

Recruitingn/aAges 50 Years - anyAllHelse Møre og Romsdal HF
NCT06458374 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male \> 50 years * Female \> 60 years * operated CTS at Ålesund Hospital Exclusion Criteria: * not consented * do not speak Norwegian * secondary cause of CTS as traumatic or rheumatic * cannot be followed \> 5 years due to other medical conditions * Cardiac disease at time of operation for CTS
💊

What it tests

  • Not listed
📍

Where

1 site
Ålesund Hospital
Ålesund, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy